BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

296 related articles for article (PubMed ID: 31202576)

  • 21. Topoisomerase II and the etiology of chromosomal translocations.
    Felix CA; Kolaris CP; Osheroff N
    DNA Repair (Amst); 2006 Sep; 5(9-10):1093-108. PubMed ID: 16857431
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Chromatin regulators mediate anthracycline sensitivity in breast cancer.
    Seoane JA; Kirkland JG; Caswell-Jin JL; Crabtree GR; Curtis C
    Nat Med; 2019 Nov; 25(11):1721-1727. PubMed ID: 31700186
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Environmental and chemotherapeutic agents induce breakage at genes involved in leukemia-causing gene rearrangements in human hematopoietic stem/progenitor cells.
    Thys RG; Lehman CE; Pierce LC; Wang YH
    Mutat Res; 2015 Sep; 779():86-95. PubMed ID: 26163765
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The broken MLL gene is frequently located outside the inherent chromosome territory in human lymphoid cells treated with DNA topoisomerase II poison etoposide.
    Glukhov SI; Rubtsov MA; Alexeyevsky DA; Alexeevski AV; Razin SV; Iarovaia OV
    PLoS One; 2013; 8(9):e75871. PubMed ID: 24086652
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Genome-wide TOP2A DNA cleavage is biased toward translocated and highly transcribed loci.
    Yu X; Davenport JW; Urtishak KA; Carillo ML; Gosai SJ; Kolaris CP; Byl JAW; Rappaport EF; Osheroff N; Gregory BD; Felix CA
    Genome Res; 2017 Jul; 27(7):1238-1249. PubMed ID: 28385713
    [TBL] [Abstract][Full Text] [Related]  

  • 26. MLL-SEPTIN6 fusion recurs in novel translocation of chromosomes 3, X, and 11 in infant acute myelomonocytic leukaemia and in t(X;11) in infant acute myeloid leukaemia, and MLL genomic breakpoint in complex MLL-SEPTIN6 rearrangement is a DNA topoisomerase II cleavage site.
    Slater DJ; Hilgenfeld E; Rappaport EF; Shah N; Meek RG; Williams WR; Lovett BD; Osheroff N; Autar RS; Ried T; Felix CA
    Oncogene; 2002 Jul; 21(30):4706-14. PubMed ID: 12096348
    [TBL] [Abstract][Full Text] [Related]  

  • 27. DNA fragility at the
    Cowell IG; Austin CA
    Open Biol; 2023 Jan; 13(1):220232. PubMed ID: 36629017
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Circular RNAs drive oncogenic chromosomal translocations within the MLL recombinome in leukemia.
    Conn VM; Gabryelska M; Toubia J; Kirk K; Gantley L; Powell JA; Cildir G; Marri S; Liu R; Stringer BW; Townley S; Webb ST; Lin H; Samaraweera SE; Bailey S; Moore AS; Maybury M; Liu D; Colella AD; Chataway T; Wallington-Gates CT; Walters L; Sibbons J; Selth LA; Tergaonkar V; D'Andrea RJ; Pitson SM; Goodall GJ; Conn SJ
    Cancer Cell; 2023 Jul; 41(7):1309-1326.e10. PubMed ID: 37295428
    [TBL] [Abstract][Full Text] [Related]  

  • 29.
    Schneidawind C; Jeong J; Schneidawind D; Kim IS; Duque-Afonso J; Wong SHK; Iwasaki M; Breese EH; Zehnder JL; Porteus M; Cleary ML
    Blood Adv; 2018 Apr; 2(8):832-845. PubMed ID: 29650777
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Dietary flavonoids induce MLL translocations in primary human CD34+ cells.
    Barjesteh van Waalwijk van Doorn-Khosrovani S; Janssen J; Maas LM; Godschalk RW; Nijhuis JG; van Schooten FJ
    Carcinogenesis; 2007 Aug; 28(8):1703-9. PubMed ID: 17468513
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Chromosomal translocations involving the MLL gene: molecular mechanisms.
    Aplan PD
    DNA Repair (Amst); 2006 Sep; 5(9-10):1265-72. PubMed ID: 16797254
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Three-dimensional genome organization in normal and malignant haematopoiesis.
    Cuartero S; Merkenschlager M
    Curr Opin Hematol; 2018 Jul; 25(4):323-328. PubMed ID: 29702522
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Detection of DNA Double-Strand Breaks and Chromosome Translocations Using Ligation-Mediated PCR and Inverse PCR.
    Singh S; Shih SJ; Vaughan ATM
    Methods Mol Biol; 2020; 2102():271-288. PubMed ID: 31989561
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Mixed-Lineage Leukemia Fusions and Chromatin in Leukemia.
    Krivtsov AV; Hoshii T; Armstrong SA
    Cold Spring Harb Perspect Med; 2017 Nov; 7(11):. PubMed ID: 28242784
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Identification of complex genomic breakpoint junctions in the t(9;11) MLL-AF9 fusion gene in acute leukemia.
    Super HG; Strissel PL; Sobulo OM; Burian D; Reshmi SC; Roe B; Zeleznik-Le NJ; Diaz MO; Rowley JD
    Genes Chromosomes Cancer; 1997 Oct; 20(2):185-95. PubMed ID: 9331569
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The MLL recombinome of acute leukemias.
    Meyer C; Schneider B; Jakob S; Strehl S; Attarbaschi A; Schnittger S; Schoch C; Jansen MW; van Dongen JJ; den Boer ML; Pieters R; Ennas MG; Angelucci E; Koehl U; Greil J; Griesinger F; Zur Stadt U; Eckert C; Szczepański T; Niggli FK; Schäfer BW; Kempski H; Brady HJ; Zuna J; Trka J; Nigro LL; Biondi A; Delabesse E; Macintyre E; Stanulla M; Schrappe M; Haas OA; Burmeister T; Dingermann T; Klingebiel T; Marschalek R
    Leukemia; 2006 May; 20(5):777-84. PubMed ID: 16511515
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Dysregulation of the DNA Damage Response and KMT2A Rearrangement in Fetal Liver Hematopoietic Cells.
    Nanya M; Sato M; Tanimoto K; Tozuka M; Mizutani S; Takagi M
    PLoS One; 2015; 10(12):e0144540. PubMed ID: 26657054
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Etoposide metabolites enhance DNA topoisomerase II cleavage near leukemia-associated MLL translocation breakpoints.
    Lovett BD; Strumberg D; Blair IA; Pang S; Burden DA; Megonigal MD; Rappaport EF; Rebbeck TR; Osheroff N; Pommier YG; Felix CA
    Biochemistry; 2001 Feb; 40(5):1159-70. PubMed ID: 11170441
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Malignant hematopoietic cell lines: in vitro models for the study of MLL gene alterations.
    Drexler HG; Quentmeier H; MacLeod RA
    Leukemia; 2004 Feb; 18(2):227-32. PubMed ID: 14671638
    [TBL] [Abstract][Full Text] [Related]  

  • 40. BRCA1 ensures genome integrity by eliminating estrogen-induced pathological topoisomerase II-DNA complexes.
    Sasanuma H; Tsuda M; Morimoto S; Saha LK; Rahman MM; Kiyooka Y; Fujiike H; Cherniack AD; Itou J; Callen Moreu E; Toi M; Nakada S; Tanaka H; Tsutsui K; Yamada S; Nussenzweig A; Takeda S
    Proc Natl Acad Sci U S A; 2018 Nov; 115(45):E10642-E10651. PubMed ID: 30352856
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.